Gene Page:CUL5
概括?
基因 | 8065 |
象征 | CUL5 |
Synonyms | Vacm-1 | Vacm1 |
Description | 卡林5 |
Reference | MIM:601741|HGNC:HGNC:2556|Ensembl:ENSG00000166266|HPRD:03444|Vega:OTTHUMG00000166369 |
Gene type | protein-coding |
Map location | 11q22.3 |
Pascal p-value | 0.314 |
eGene | Myers' cis & trans |
Support | G2Cdb.humanPSD G2Cdb.humanPSP |
数据源中的基因
Gene set name | Method of gene set | Description | Info |
---|---|---|---|
CV:GWASDB | Genome-wide Association Studies | GWASdb records for schizophrenia | |
CV:PGCnp | Genome-wide Association Study | GWAS | |
GSMA_I | Genome scan meta-analysis | PSR:0.006 | |
Network | 人蛋白蛋白质相互作用网络中核心基因的最短路径距离 | Contribution to shortest path in PPI network: 0.0125 |
第一节遗传学和表观遗传学注释
eQTL annotation
SNP ID | Chromosome | Position | eGene | Gene Entrez ID | pvalue | qvalue | TSS distance | eQTL type |
---|---|---|---|---|---|---|---|---|
rs7132043 | chr12 | 80968399 | CUL5 | 8065 | 0.1 | trans |
Section II. Transcriptome annotation
General gene expression (GTEx)
![Not available](http://www.tjghsg.com/bioinfo/SZGR/GeneImg/CUL5_DE_GTEx.png)
Gene expression of temporal and spatial changes (BrainSpan)
脚注:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes the lower 25% and upper 25% of the expression distribution.
No co-expressed genes in brain regions
Section III. Gene Ontology annotation
Molecular function | GO term | Evidence | Neuro keywords | PubMed ID |
---|---|---|---|---|
GO:0004872 | receptor activity | TAS | 9581826 | |
GO:0005515 | protein binding | 新闻学会 | 12504025 | |
去:0005262 | calcium channel activity | TAS | 9581826 | |
GO:0031625 | ubiquitin protein ligase binding | IEA | - | |
生物过程 | GO term | Evidence | Neuro keywords | PubMed ID |
GO:0000082 | G1/S transition of mitotic cell cycle | TAS | 8681378 | |
GO:0006511 | ubiquitin-dependent protein catabolic process | IEA | - | |
GO:0007050 | cell cycle arrest | TAS | 8681378 | |
GO:0008285 | negative regulation of cell proliferation | TAS | 8681378 | |
GO:0008629 | induction of apoptosis by intracellular signals | TAS | 9581826 | |
GO:0044419 | interspecies interaction between organisms | IEA | - | |
Cellular component | GO term | Evidence | Neuro keywords | PubMed ID |
GO:0005794 | Golgi apparatus | IDA | 18029348 | |
GO:0005829 | cytosol | 经验 | 14564014|15781449 | |
GO:0005737 | 细胞质 | IDA | 18029348 | |
GO:0031461 | 卡林环泛素连接酶复合物 | IEA | - |
V.途径注释
Pathway name | Pathway size | # SZGR 2.0 genes in pathway | Info |
---|---|---|---|
KEGG UBIQUITIN MEDIATED PROTEOLYSIS | 138 | 98 | 该途径中的所有SZGR 2.0基因 |
ERBB2的Reactome信号传导 | 101 | 78 | 该途径中的所有SZGR 2.0基因 |
REACTOME HIV INFECTION | 207 | 122 | 该途径中的所有SZGR 2.0基因 |
REACTOME HOST INTERACTIONS OF HIV FACTORS | 132 | 81 | 该途径中的所有SZGR 2.0基因 |
REACTOME IMMUNE SYSTEM | 933 | 616 | 该途径中的所有SZGR 2.0基因 |
REACTOME适应性免疫系统 | 539 | 350 | 该途径中的所有SZGR 2.0基因 |
REACTOME CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION | 251 | 156 | 该途径中的所有SZGR 2.0基因 |
REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | 212 | 129 | 该途径中的所有SZGR 2.0基因 |
REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | 52 | 30 | 该途径中的所有SZGR 2.0基因 |
GAZDA DIAMOND BLACKFAN ANEMIA ERYTHROID DN | 493 | 298 | 该途径中的所有SZGR 2.0基因 |
DIAZ CHRONIC MEYLOGENOUS LEUKEMIA UP | 1382 | 904 | 该途径中的所有SZGR 2.0基因 |
DEURIG T CELL PROLYMPHOCYTIC LEUKEMIA DN | 320 | 184 | 该途径中的所有SZGR 2.0基因 |
DODD NASOPHARYNGEAL CARCINOMA UP | 1821 | 933 | 该途径中的所有SZGR 2.0基因 |
RODRIGUES THYROID CARCINOMA ANAPLASTIC UP | 722 | 443 | 该途径中的所有SZGR 2.0基因 |
LASTOWSKA NEUROBLASTOMA COPY NUMBER DN | 800 | 473 | 该途径中的所有SZGR 2.0基因 |
LINDGREN BLADDER CANCER WITH LOH IN CHR9Q | 116 | 71 | 该途径中的所有SZGR 2.0基因 |
SCHLOSSER SERUM RESPONSE AUGMENTED BY MYC | 108 | 74 | 该途径中的所有SZGR 2.0基因 |
SPIELMAN LYMPHOBLAST EUROPEAN VS ASIAN DN | 584 | 395 | 该途径中的所有SZGR 2.0基因 |
PUJANA ATM PCC NETWORK | 1442 | 892 | 该途径中的所有SZGR 2.0基因 |
NUYTTEN NIPP1 TARGETS DN | 848 | 527 | 该途径中的所有SZGR 2.0基因 |
NUYTTEN EZH2 TARGETS DN | 1024 | 594 | 该途径中的所有SZGR 2.0基因 |
BENPORATH MYC MAX TARGETS | 775 | 494 | 该途径中的所有SZGR 2.0基因 |
GEORGES CELL CYCLE MIR192 TARGETS | 62 | 46 | 该途径中的所有SZGR 2.0基因 |
GEORGES TARGETS OF MIR192 AND MIR215 | 893 | 528 | 该途径中的所有SZGR 2.0基因 |
SHEN SMARCA2 TARGETS UP | 424 | 268 | 该途径中的所有SZGR 2.0基因 |
BLALOCK ALZHEIMERS DISEASE UP | 1691年 | 1088 | 该途径中的所有SZGR 2.0基因 |
LINDVALL IMMORTALIZED BY TERT DN | 80 | 56 | 该途径中的所有SZGR 2.0基因 |
IVANOVA HEMATOPOIESIS INTERMEDIATE PROGENITOR | 149 | 84 | 该途径中的所有SZGR 2.0基因 |
IVANOVA HEMATOPOIESIS STEM CELL AND PROGENITOR | 681 | 420 | 该途径中的所有SZGR 2.0基因 |
DE YY1 TARGETS DN | 92 | 64 | 该途径中的所有SZGR 2.0基因 |
ACEVEDO LIVER CANCER UP | 973 | 570 | 该途径中的所有SZGR 2.0基因 |
WEST ADRENOCORTICAL TUMOR DN | 546 | 362 | 该途径中的所有SZGR 2.0基因 |
SAKAI CHRONIC HEPATITIS VS LIVER CANCER UP | 83 | 63 | 该途径中的所有SZGR 2.0基因 |
DANG BOUND BY MYC | 1103 | 714 | 该途径中的所有SZGR 2.0基因 |
NIELSEN GIST | 98 | 66 | 该途径中的所有SZGR 2.0基因 |
JOHNSTONE PARVB TARGETS 2 DN | 336 | 211 | 该途径中的所有SZGR 2.0基因 |
PLASARI TGFB1 SIGNALING VIA NFIC 1HR DN | 106 | 77 | 该途径中的所有SZGR 2.0基因 |
Section VI. microRNA annotation
miRNA family | Target position | miRNA ID | miRNA seq | ||
---|---|---|---|---|---|
UTR start | UTR end | Match method | |||
miR-124.1 | 120 | 126 | m8 | hsa-miR-124a | UUAAGGCACGCGGUGAAUGCCA |
miR-124/506 | 120 | 126 | 1A | hsa-miR-506 | UAAGGCACCCUUCUGAGUAGA |
hsa-miR-124brain | UAAGGCACGCGGUGAAUGCC | ||||
miR-148/152 | 393 | 400 | 1A,m8 | hsa-miR-148a | UCAGUGCACUACAGAACUUUGU |
hsa-miR-152brain | UCAGUGCAUGACAGAACUUGGG | ||||
hsa-miR-148b | UCAGUGCAUCACAGAACUUUGU | ||||
miR-181 | 3212 | 3218 | m8 | hsa-miR-181abrain | aacauucaacgcugucggugagu |
hsa-miR-181bSZ | AACAUUCAUUGCUGUCGGUGGG | ||||
hsa-miR-181cbrain | AACAUUCAACCUGUCGGUGAGU | ||||
hsa-miR-181dbrain | AACAUUCAUUGUUGUCGGUGGGUU | ||||
miR-182 | 1123 | 1130 | 1A,m8 | hsa-miR-182 | uuuggcaaugguagaacucaca |
miR-186 | 2255 | 2261 | 1A | hsa-miR-186 | CAAAGAAUUCUCCUUUUGGGCUU |
miR-19 | 189 | 195 | 1A | hsa-miR-19a | UGUGCAAAUCUAUGCAAAACUGA |
hsa-miR-19b | ugugcaaauccaugcaaaacuga | ||||
miR-217 | 3277 | 3284 | 1A,m8 | hsa-miR-217 | UACUGCAUCAGGAACUGAUUGGAU |
miR-299-5p | 1923 | 1929 | 1A | hsa-miR-299-5p | UGGUUUACCGUCCCACAUACAU |
miR-31 | 1122 | 1128 | 1A | hsa-miR-31 | AGGCAAGAUGCUGGCAUAGCUG |
miR-324-5p | 3056 | 3062 | m8 | hsa-miR-324-5p | CGCAUCCCCUAGGGCAUUGGUGU |
miR-33 | 2023 | 2029 | 1A | hsa-miR-33 | GUGCAUUGUAGUUGCAUUG |
HSA-MIR-33B | GUGCAUUGCUGUUGCAUUGCA | ||||
mir-370 | 643 | 649 | 1A | hsa-miR-370brain | GCCUGCUGGGGUGGAACCUGG |
miR-381 | 3335 | 3341 | 1A | hsa-miR-381 | uauacaagggcaagcucucugu |
miR-410 | 1148 | 1154 | 1A | hsa-miR-410 | aauauaacacagauggcugu |
miR-433-3p | 234 | 240 | 1A | hsa-miR-433brain | AUCAUGAUGGGCUCCUCGGUGU |
mir-493-5p | 1134 | 1140 | m8 | hsa-miR-493-5p | UUGUACAUGGUAGGCUUUCAUU |
mir-96 | 1124 | 1130 | 1A | hsa-miR-96brain | UUUGGCACUAGCACAUUUUUGC |